Literature DB >> 16456432

Cystogram follow-up in the management of traumatic bladder disruption.

Kenji Inaba1, Mark McKenney, Felipe Munera, Marc de Moya, Peter P Lopez, Carl I Schulman, Fahim A Habib.   

Abstract

BACKGROUND: The utility of obtaining a routine cystogram after the repair of intraperitoneal bladder disruption before urethral catheter removal is unknown. This study was designed to examine whether follow-up cystogram evaluation after traumatic bladder disruption affected the clinical management of these injuries. We hypothesized that routine cystograms, after operative repair of intraperitoneal bladder disruptions, provide no clinically useful information and may be eliminated in the management of these injuries.
METHODS: Our prospectively collected trauma database was retrospectively reviewed for all ICD-9 867.0 and 867.1 coded bladder injuries over a 6-year period ending in June 2004. Demographics, clinical injury data, detailed operative records, and imaging studies were reviewed for each patient. Bladder injuries were categorized as intraperitoneal (IP) or extraperitoneal (EP) bladder disruptions based on imaging results and operative exploration. Patients with IP injuries were further subdivided into those with "simple" dome disruptions or through-and-through penetrating injuries and "complex" injuries involving the trigone or ureter reimplantation. All patients sustaining isolated ureteric or urethral injury were excluded from further analysis.
RESULTS: In all, 20,647 trauma patients were screened for bladder injury. Out of this group, there were 50 IP (47 simple, 3 complex) and 37 EP injuries available for analysis. All IP injuries underwent operative repair. Eight of the IP injuries (all simple) had no postoperative cystogram and all were doing well at 1- to 4-week follow-up. The remaining 42 patients underwent a postoperative cystogram at 15.3 +/- 7.3 days (range 7 to 36 days). All simple IP injuries had a negative postoperative cystogram. The only positive study was in one of the three complex IP injuries. In the EP group, 21.6% had positive cystograms requiring further follow-up and intervention.
CONCLUSIONS: Patients sustaining extraperitoneal and complex intraperitoneal bladder disruptions require routine cystogram follow-up. In those patients undergoing repair of a simple intraperitoneal bladder disruption, however, routine follow-up cystograms did not affect clinical management. Further prospective evaluation to determine the optimal timing of catheter removal in this patient population is warranted.

Entities:  

Mesh:

Year:  2006        PMID: 16456432     DOI: 10.1097/01.ta.0000200096.44452.8a

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  5 in total

1.  Urotrauma: AUA guideline.

Authors:  Allen F Morey; Steve Brandes; Daniel David Dugi; John H Armstrong; Benjamin N Breyer; Joshua A Broghammer; Bradley A Erickson; Jeff Holzbeierlein; Steven J Hudak; Jeffrey H Pruitt; James T Reston; Richard A Santucci; Thomas G Smith; Hunter Wessells
Journal:  J Urol       Date:  2014-05-20       Impact factor: 7.450

2.  Perioperative Management of Patients with Colovesical Fistula.

Authors:  Scott C Dolejs; Alyssa J Penning; Michael J Guzman; Alyssa D Fajardo; Bryan K Holcomb; Bruce W Robb; Joshua A Waters
Journal:  J Gastrointest Surg       Date:  2018-11-08       Impact factor: 3.452

3.  Lower urinary tract injuries following blunt trauma: a review of contemporary management.

Authors:  Jennifer P L Kong; Matthew F Bultitude; Peter Royce; Russell L Gruen; Alex Cato; Niall M Corcoran
Journal:  Rev Urol       Date:  2011

Review 4.  When the bowel meets the bladder: Optimal management of colorectal pathology with urological involvement.

Authors:  Conor Keady; Daniel Hechtl; Myles Joyce
Journal:  World J Gastrointest Surg       Date:  2020-05-27

5.  Management of blunt intraperitoneal bladder rupture: Case report and literature review.

Authors:  Adel Elkbuli; John D Ehrhardt; Shaikh Hai; Mark McKenney; Dessy Boneva
Journal:  Int J Surg Case Rep       Date:  2019-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.